Brain scan targeting to improve specific depression symptoms
Part of Mental health clinical trials.
This study uses brain-signal targeting (likely with MRI) to see whether it can improve certain symptoms of depression. You may be able to join if you’re 18–65 and currently have a depressive episode, and if you can safely complete the scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 65 years old
- You can understand the study and sign consent
- If you join as a patient, you’re currently in a major depressive episode
- You cannot have bipolar (mania/hypomania) or a primary psychotic disorder
- You must not have certain brain or seizure history, and you must be safe for MRI
- You must avoid metal/implants that don’t mix with MRI, and you can’t be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a type of brain stimulation (guided iTBS) to improve depression when standard antidepressant treatments haven’t helped. It also checks that the treatment is safe for people who can meet the study and scan safety requirements.
This study tests whether an “accelerated intermittent theta-burst” brain stimulation treatment can improve major depressive disorder by affecting brain signaling pathways. You may be a candidate if you have moderate-to-severe depression and can safely undergo brain MRI.
This study tests if a type of brain stimulation (TMS) can improve brain function in people with depression. It also includes a small group of epilepsy patients who are already having brain monitoring. The goal is to find new ways to treat depression by targeting specific brain areas.
This trial tests a new type of brain stimulation called theta-burst stimulation to see if it helps treat depression. It is for people aged 18-50 who are currently experiencing a major depressive episode and are on a stable antidepressant regimen.
This trial tests a new way of delivering a non-invasive brain stimulation treatment called iTBS for depression. The treatment is personalized based on brain scans, and the study aims to see if it can help reduce depressive symptoms.
This study tests whether a non-invasive brain stimulation technique (called iTBS) can improve attention problems in people with major depression. If you have depression and trouble focusing, this trial might help understand a new treatment option.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.